Utility of testing bronchoalveolar lavage fluid for cryptococcal ribosomal DNA

Area of Science:

• Medical Microbiology
• Infectious Diseases
• Molecular Diagnostics

Background:

• Cryptococcus neoformans is an opportunistic pathogen causing pulmonary infections, particularly in immunocompromised individuals.
• Bronchoalveolar lavage (BAL) is a diagnostic tool for pulmonary infections.
• Accurate and timely diagnosis of cryptococcosis is crucial for patient management.

Purpose of the Study:

• To evaluate the utility of detecting Cryptococcus neoformans in BAL specimens using various methods.
• To assess the role of molecular detection (PCR) of C. neoformans ribosomal DNA (rDNA) in BAL fluid.
• To compare the performance of staining, culture, antigen testing, and PCR for diagnosing pulmonary cryptococcosis.

Main Methods:

• Analysis of BAL specimens from 88 patients, including HIV-infected, non-HIV immunosuppressed, and immunocompetent individuals.
• Conventional methods: Gram staining and culture for C. neoformans.
• Antigen testing for Cryptococcus neoformans.
• Molecular detection of C. neoformans rDNA using polymerase chain reaction (PCR).

Main Results:

• C. neoformans was detected by staining and culture in two HIV-infected patients with pulmonary cryptococcosis; antigen and PCR tests were also positive.
• PCR detected C. neoformans rDNA in one non-HIV immunocompromised patient with Pneumocystis pneumonia, but other tests were negative.
• Antigen testing was positive in an immunocompetent patient with sarcoidosis, while staining, culture, and PCR were negative.

Conclusions:

• The detection of C. neoformans rDNA by PCR in BAL specimens showed limited additional diagnostic value beyond conventional methods in this cohort.
• False positive or non-specific results from molecular or antigen tests can occur, potentially complicating diagnosis.
• Routine testing of BAL specimens for C. neoformans rDNA is not supported by these findings and may not be clinically beneficial.